#biotech

#biotech

Gameto, a biotech company focused on women's reproductive health using cell engineering, has raised $44M in Series C funding led by Overwater Ventures.

A well-known adage reminds us that corporate insiders and 10% owners really only buy shares of a company because they believe the stock price will rise and they want to profit from it.

Concentra Biosciences is rapidly acquiring struggling biotech companies, taking advantage of Bay Area firms' difficulties, including its recent purchase of Cargo Therapeutics, which faced severe setbacks this year.

Colossal Biosciences claims to have restored the dire wolf, but in reality, they merely edited gray wolf genes, raising questions about species definition.

The market for these instruments has clearly evaporated due to government funding cuts, pushing Eikon to pause the development of advanced lab tools for researchers.